[1]
|
L. A. Bagatolli, “Membranes and Fluorescence Microscopy,” Reviews in Fluorescence, Vol. 4, No. 1, 2007, pp. 33-51.
|
[2]
|
J. R. Silvius and I. R. Nabi, “Fluorescence-Quenching and Resonance Energy Transfer Studies of Lipid Microdomains in Model and Biological Membranes,” Molecular Membrane Biology, Vol. 23, No. 1, 2006, pp. 5-16.
doi:10.1080/09687860500473002
|
[3]
|
J. R. Lakowicz, “Principles of Fluorescence Spectroscopy,” 3rd Edition, New York, Springer, 2006.
doi:10.1007/978-0-387-46312-4
|
[4]
|
J. W. Taraska, ‘Mapping Membrane Protein Structure with Fluorescence,” Current Opinion in Structural Biology, Vol. 22, No. 4, 2012, pp. 507-513.
doi:10.1016/j.sbi.2012.02.004
|
[5]
|
L. A. Munishkina and A. L. Fink, “Fluorescence as a Method to Reveal Structures and Membrane-Interactions of Amyloidogenic Proteins,” BBA, Vol. 1768, No. 8, 2007, pp. 1862-1885. doi:10.1016/j.bbamem.2007.03.015
|
[6]
|
C. M. Reyes, R. F. de Almeida, L. M. S. Loura and M. Prieto, “From Lipid Phases to Membrane Protein Organization: Fluorescence Methodologies in the Study of Lipid-Protein Interactions,” In: C. R. Mateo, et al., Ed., Springer Series in Biophysics, Protein-Lipid Interactions Springer-Verlag Berlin Heidelgerg, Berlin, Vol. 9, 2006.
|
[7]
|
I. Plasencia, A. Cruz, C. Casals and J. Perez-Gil, “Superficial Disposition of the N-Terminal Region of the Surfactant Protein SP-C and the Absence of Specific SP-B-SP-C Interactions in Phospholipid Bilayers,” Biochemical Journal, Vol. 359, 2001, pp. 651-659.
doi:10.1042/0264-6021:3590651
|
[8]
|
O. Maier, V. Oberle and D. Hoekstra, “Fluorescent Lipid Probes: Some Properties and Applications (A Review),” Chemistry and Physics of Lipids, Vol. 116, No. 1-2, 2002, pp. 3-18. doi:10.1016/S0009-3084(02)00017-8
|
[9]
|
J. Kaylor, N. Bodner, S. Edridge, G. Yamin, D. P. Hong and A. L. Fink, “Characterization of Oligomeric Intermediates in Alpha-Synuclein Fibrillation FRET Studies of Y125W/Y133F/Y136F Alpha-Synuclein,” Journal of Molecular Biology, Vol. 353, No. 2, 2005, pp. 357-372.
doi:10.1016/j.jmb.2005.08.046
|
[10]
|
A. Dusa, J. Kaylor, S. Edridge, N. Bodner, D. P. Hong and A. L. Fink, “Characterization of Oligomers during Alpha-Synuclein Aggregation Using Intrinsic Tryptophan Fluorescence,” Biochemistry, Vol. 45, No. 8, 2006, pp. 2752-2760. doi:10.1021/bi051426z
|
[11]
|
K. L. Lim, F. L. Dawson and T. M. Dawson, “The Best of Molecular Characters in Parkinson’s Disease: Felons, Conspirators and Suspects,” Annals of the New York Academy of Sciences, Vol. 991, No. 1, 2003, pp. 80-92.
doi:10.1111/j.1749-6632.2003.tb07465.x
|
[12]
|
A. Siderowf and M. Stern, “Update on Parkinson Disease,” Annals of Internal Medicine, Vol. 138, No. 8, 2003, pp. 651-658.
|
[13]
|
T. T. Warner and A. H. Schapira, “Genetic and Environmental Factors in the Cause of Parkinson’s Disease,” Annals of Neurology, Vol. 53 Suppl 3, 2003, pp. S16-S23.
doi:10.1002/ana.10487
|
[14]
|
A. Demuro, E. Mina, R. Kayed, S. C. Milton, I. Parker and C. G. Glabe, “Calcium Dysregulation and Membrane Disrpution as Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers,” The Journal of Biological Chemistry, Vol. 280, No. 17, 2005, pp. 17294-17300.
doi:10.1074/jbc.M500997200
|
[15]
|
A. L. Fink, “The Aggregation and Fibrillation of Alpha-Synuclein,” Accounts of Chemical Research, Vol. 39, No. 9, 2006, pp. 628-634. doi:10.1021/ar050073t
|
[16]
|
R. Kayed, E. Head, J. L. Thompson, S. C. Milton, C. W. Cotman and C. G. Glabe, “Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis,” Science, Vol. 300, No. 5618, 2003, pp. 486-489. doi:10.1126/science.1079469
|
[17]
|
M. J. Volles and P. T. Lansbury Jr., “Zeroing in on the Pathogenic Form of Alpha-Synuclein and Its Mechanism of Neurotoxicity in Parkinson’s Disease,” Biochemistry, Vol. 42, No. 26, 2003, pp. 7871-7878.
doi:10.1021/bi030086j
|
[18]
|
K. M. Danzer, D. Haasen, A. R. Karow, S. Moussaud, M. Habeck, A. Giese, H. Kretzschmar, B. Hengerer and M. Kostka, “Different Species of Alpha-Synuclein Oligomers Induce Calcium Influx and Seeding,” The Journal of Neuroscience, Vol. 27, No. 34, 2007, pp. 9220-9232.
doi:10.1523/JNEUROSCI.2617-07.2007
|
[19]
|
M. S. Goldberg and P. T. Lansbury, “Is There a Cause- And-Effect Relationship between Alpha-Synuclein Fibrillization and Parkinson’s Disease?” Nature Cell Biology, Vol. 2, No. 7, 2000, pp. E115-E119.
doi:10.1038/35041081
|
[20]
|
H. Y. Kim, et al., “Structural Properties of Pore-Forming Oligomers of Synuclein,” Journal of the American Chemical Society, Vol. 131, No. 47, 2009, pp. 17482-17489.
doi:10.1021/ja9077599
|
[21]
|
H. A. Lashuel, D. Hartley, B. M. Petre, T. Walz and P. T. Lansbury, “Neurodegenerative Disease-Amyloid Pores from Pathogenic Mutations,” Nature, Vol. 418, No. 6895, 2002, pp. 291-300. doi:10.1038/418291a
|
[22]
|
M. J. Volles and P. T. Lansbury Jr., “Vesicle Permeabilization by Protofibrillar Alpha-Synuclein Is Sensitive to Parkinson’s Disease-Linked Mutations and Occurs by a Pore-Like Mechanism,” Biochemistry, Vol. 41, No. 14, 2002, pp. 4595-4602. doi:10.1021/bi0121353
|
[23]
|
H. A. Lashuel, B. M. Petre, J. Wall, M. Simon, R. J. Nowak, T. Walz and P. T. Lansbury Jr., “Alpha-Synuclein, Especially the Parkinson’s Disease-Associated Mutants Forms Pore-Like Annular and Tubular Protofibrils,” Journal of Molecular Biology, Vol. 322, No. 5, 2002, pp. 1089-1102. doi:10.1016/S0022-2836(02)00735-0
|
[24]
|
L. Maroteaux, J. T. Campanelli and R. H. Scheller, “Synuclein: A Neuron Specific Protein Localized to the Nucleus and Presynaptic Nerve Terminal,” The Journal of Neuroscience, Vol. 8, No. 8, 1988, pp. 2804-2815.
|
[25]
|
P. H. Weinreb, W. Zhen, A. W. Poon, K. A. Conway and P. T. Lansbury Jr., “NACP a Protein Implicated in Alzheimer’s Disease and Learning Is Natively Unfolded,” Biochemistry, Vol. 35, No. 43, 1996, pp. 13709-13715.
doi:10.1021/bi961799n
|
[26]
|
R. Bussell, T. F. Ramlall and D. Eliezer, “Helix Periodicity, Topology and Dynamics of Membrane-Associated Alpha-Synuclein,” Protein Science, Vol. 14, No. 4, 2005, pp. 862-872. doi:10.1110/ps.041255905
|
[27]
|
W. S. Davidson, A. Jonas, D. F. Clayton and J. M. George, “Stabilization of Alpha-Synuclein Secondary Structure upon Binding to Synthetic Membranes,” The Journal of Biological Chemistry, Vol. 273, No. 16, 1998, pp. 9443-9449.
doi:10.1074/jbc.273.16.9443
|
[28]
|
K. A. Conway, J. D. Harper and P. T. Lansbury Jr., “Fibrils Formed in Vitro from Alpha-Synuclein and Two Mutants Forms Linked to Parkinsons’s Disease Are Typical Amyloid,” Biochemistry, Vol. 39, No. 10, 2000, pp. 2552-2563.
|
[29]
|
M. Zhu, J. Li and A. L. Fink, “The Association of α-Synuclein with Membranes Affects Bilayer Structure, Stability and Fibril Formation,” The Journal of Biological Chemistry, Vol. 278, No. 41, 2003, pp. 40186-40197.
doi:10.1074/jbc.M305326200
|
[30]
|
S. Chandra, X. Chen, J. Rizo, R. Jahn and T. C. Sudhof, “A Broken Alpha A Broken Alpha-Helix in Folded Alpha-Synuclein,” The Journal of Biological Chemistry, Vol. 278, No. 17, 2003, pp. 15313-15318.
doi:10.1074/jbc.M213128200
|
[31]
|
C. M. Pfefferkorn and J. C. Lee, “Tryptophan Probes at the α-Synuclein and Membrane Interface,” The Journal of Physical Chemistry B, Vol. 114, No. 13, 2010, pp. 4615-4622. doi:10.1021/jp908092e
|
[32]
|
V. N. Uversky, J. Li and A. L. Fink, “Evidence for a Partially Folded Intermediate in Alpha-Synuclein Fibril Formation,” The Journal of Biological Chemistry, Vol. 276, No. 14, 2001, pp. 10737-10744.
|
[33]
|
J. C. Lee, R. Langen, P. A. Hummel, H. B. Gray and J. R. Winkler, “Alpha-Synuclein Structures from Fluorescence Energy-Transfer Kinetics: Implications for the Role of the Protein in Parkinson’s Disease,” Proceedings of the National Academy of Sciences of the United States of America, Vol. 101, No. 47, 2004, pp. 16466-16471.
doi:10.1073/pnas.0407307101
|
[34]
|
D. Sulzer, “Clues to How α-Synuclein Damages Neurons in Parkinson’s Disease,” Movement Disorders, Vol. 25 Suppl 1, 2010, pp. S27-S31. doi:10.1002/mds.22639
|
[35]
|
K. Furukawa, et al., “Plasma Membrane Ion Permeability Induced by Mutant α-Synuclein Contributes to the Degeneration of Neural Cells,” Journal of Neurochemistry, Vol. 97, No. 4, 2006, pp. 1071-1077.
doi:10.1111/j.1471-4159.2006.03803.x
|
[36]
|
B. D. van Rooijen, M. M. A. E. Claessens and V. Subramaniam, “Membrane Binding of Oligomeric Alpha-Synuclein Depends on Bilayer Charge and Packing,” FEBS Letters, Vol. 582, No. 27, 2008, pp. 3788-3792.
doi:10.1016/j.febslet.2008.10.009
|
[37]
|
M. T. Stockl, N. Zijlstra and V. Subramaniam, “α-Synu-Clein Oligomers: An Amyloid Pore?” Molecular Neurobiology, 2012. doi:10.1007/s12035-012-8331-4
|
[38]
|
M. Stockl, P. Fischer, E. Wanker and A. Hermann, “Alpha Synuclein Selectively Binds to Anionic Phospholipids Embedded in Liquid-Disordered Domains,” Journal of Molecular Biology, Vol. 375, No. 5, 2008, pp. 1394-1404. doi:10.1016/j.jmb.2007.11.051
|
[39]
|
B. D. van Rooijen, M. M. A. E. Claessens and V. Subramaniam, “Lipid Bilayer Disruption by Oligomeric Alpha-Synuclein Depends on Bilayer Charge and Accessibility of the Hydrophobic Core,” Biochim Biophys Acta Biomembr, Vol. 1788, No. 6, 2009, pp. 1271-1278.
doi:10.1016/j.bbamem.2009.03.010
|
[40]
|
M. St?ckl, M. M. Claessens and V. Subramaniam, “Kinetic Measurements Give New Inshights into Lipid Membrane Permeabilization by Alpha-Synuclein Oligomers,” Molecular BioSystems, Vol. 8, No. 1, 2012, pp. 338-345.
doi:10.1039/c1mb05293d
|
[41]
|
J. E. Shaw, R. F. Epand, R. M. Epand, Z. Li, R. Bittman and C. M. Yip, “Correlated Fluorescence-Atomic Force Microscopy of Membrane Domains: Structure of Fluorescence Probes Determines Lipid Localization,” Biophysical Journal, Vol. 90, No. 6, 2006, pp. 2170-2178.
doi:10.1529/biophysj.105.073510
|
[42]
|
M. Stockl, P. Fischer, E. Wanker and A. Herrmann, “α-Synuclein Selectively Binds to Anionic Phospholipids Embedded in Liquid-Disordered Domains,” Journal of Molecular Biology, Vol. 375, No. 5, 2008, pp. 1394-1404.
doi:10.1016/j.jmb.2007.11.051
|
[43]
|
B. D. van Rooijen, M. M. A. E. Claessens and V. Subramaniam, “Membrane Permeabilization by Oligomeric α-Synuclein: In Search of the Mechanism,” Plos One, Vol. 5, No. 12, 2010, Article ID: e14292.
doi:10.1371/journal.pone.0014292
|